PPARG and cancer: Jang Hyun Choi and colleagues at the Ulsan National Institute of Science and Technology, Korea, have found that TRIM25, a protein implicated in cancer and antiviral immune responses, reduces the activity of PPARγ by adding a small regulatory protein that acts as a signal for degradation.